Department of Endocrinology and Metabolism, Chukyo Hospital, Nagoya 457-8510, Japan.
Diabetes Res Clin Pract. 2009 Nov;86(2):e19-21. doi: 10.1016/j.diabres.2009.08.009. Epub 2009 Sep 9.
Currently, a combination therapy of pegylated (PEG) interferon (IFN) alpha-2b and ribavirin are being widely used for the treatment of chronic hepatitis C (CHC). We describe here a case of dual onset of type 1 DM accompanied by ketoacidosis, and Graves' disease during the combination therapy via the autoimmune process.
目前,聚乙二醇(PEG)干扰素(IFN)α-2b 和利巴韦林联合治疗被广泛用于慢性丙型肝炎(CHC)的治疗。我们在此描述了一例在联合治疗过程中通过自身免疫过程发生的 1 型糖尿病伴酮症酸中毒和格雷夫斯病双重发作的病例。